Thymalin
Polypeptide preparation extracted from bovine thymus, used in immunology research.
Prepared to order · approx. 7 days + Royal Mail Tracked 24
SKU BP-THYM-10 · per batch COA · Lyophilised powder
Note: Animal-derived (bovine) material: source, TSE/BSE documentation and composition must be confirmed with the supplier. The ≥99% purity specification does not apply to an extract. Purity specification to be confirmed against the supplier COA.
Thymalin overview
Thymalin is a complex of polypeptides extracted from calf (bovine) thymus tissue, so it is a mixture rather than a single defined sequence. It is supplied as a lyophilised solid for in-vitro laboratory research.
Thymalin research background
Evidence status: Little peer-reviewed research is publicly available for this compound. They are not established effects in humans, have not been evaluated by the MHRA, and are provided for scientific context only. This product is supplied strictly for laboratory research and is not for human or veterinary use.
Established research
Peer-reviewed published findings, with referencesOverview & discovery history
Chemical identity
Identity values are confirmed per lot on the certificate of analysis. Salt/counter-ion form (e.g. acetate or TFA) is stated on the COA where applicable.
Mechanisms investigated
Research areas & model types
Human clinical research status
- No controlled trials in international peer-reviewed journals were identified. It is not authorised as a medicine in the UK.
Safety observations reported in studies
- As an animal-derived mixture, its composition may vary between batches.
Known limitations
- The literature is limited and the composition is not fully defined.
Storage & handling for laboratory use
Store at −20 °C. Protect from light.
Store lyophilised material sealed at −20 °C or below, protected from light and moisture. Allow the vial to equilibrate to room temperature before opening to limit condensation.
- Allow the sealed vial to reach room temperature before opening to limit condensation.
- Any solutions should be prepared only for in-vitro laboratory work under your own validated protocol; aliquoting limits repeated freeze–thaw cycles.
- Handle with standard laboratory PPE in line with your risk assessment and the Safety Data Sheet (SDS). Britpep does not provide preparation or administration guidance.
Emerging & theoretical
Unconfirmed — hypotheses & ongoing researchThese are unconfirmed hypotheses and early-stage lines of enquiry, not established effects. Not evaluated by the MHRA. Not for human or veterinary use.
Hypotheses proposed by researchers
- The originating researchers propose that short peptides within the complex regulate gene expression [2].
Preprints: none included (no relevant preprint could be verified). Anecdotal, user-reported or social-media material is deliberately excluded.
References
- Khavinson VK, Linkova NS, Kvetnoy IM et al.. Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. Bull Exp Biol Med. 2020. PubMed 33237528 · doi:10.1007/s10517-020-05016-z
- Linkova N, Khavinson V, Diatlova A et al.. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. Int J Mol Sci. 2023. PubMed 37686182 · doi:10.3390/ijms241713377
Every reference was checked against PubMed (NCBI) before publication. Summaries describe published research only and are not claims of any effect in humans or animals.
Certificates of analysis
[No batch COA published yet. The certificate for each lot will be listed here and in the COA checker before release.]
